These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 19762282

  • 1. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G, Contini P, Setti M, Cagnati P, Lantieri F, Indiveri F, Puppo F.
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [Abstract] [Full Text] [Related]

  • 2. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.
    Murdaca G, Contini P, Setti M, Cagnati P, Villa R, Lantieri F, Indiveri F, Puppo F.
    Hum Immunol; 2007 Nov; 68(11):894-900. PubMed ID: 18082568
    [Abstract] [Full Text] [Related]

  • 3. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
    Ciprandi G, Continia P, Fenoglio D, Sormani MP, Negrini S, Puppo F, Indiveri F.
    Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
    [Abstract] [Full Text] [Related]

  • 4. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
    Ciprandi G, Contini P, Pistorio A, Murdaca G, Puppo F.
    Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
    [Abstract] [Full Text] [Related]

  • 5. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
    Ciprandi G, Colombo BM, Contini P, Cagnati P, Pistorio A, Puppo F, Murdaca G.
    Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.
    Donaghy L, Gros F, Amiot L, Mary C, Maillard A, Guiguen C, Gangneux JP.
    Clin Exp Immunol; 2007 Feb; 147(2):236-40. PubMed ID: 17223963
    [Abstract] [Full Text] [Related]

  • 10. Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.
    Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [Abstract] [Full Text] [Related]

  • 11. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN, Shang H, Jiang YJ, Liu J, Dai D, Diao YY, Geng WQ, Jin X, Wang YN.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1966-71. PubMed ID: 17199940
    [Abstract] [Full Text] [Related]

  • 12. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
    Rebmann V, Bartsch D, Wunsch A, Möllenbeck P, Golda T, Viebahn R, Grosse-Wilde H.
    Hum Immunol; 2009 Dec 05; 70(12):995-9. PubMed ID: 19651178
    [Abstract] [Full Text] [Related]

  • 13. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 05; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.
    Brumme ZL, Brumme CJ, Chui C, Mo T, Wynhoven B, Woods CK, Henrick BM, Hogg RS, Montaner JS, Harrigan PR.
    J Infect Dis; 2007 Jun 01; 195(11):1694-704. PubMed ID: 17471440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy.
    Gaardbo JC, Nielsen SD, Vedel SJ, Ersbøll AK, Harritshøj L, Ryder LP, Nielsen JO, Kolte L.
    Clin Exp Immunol; 2008 Oct 01; 154(1):80-6. PubMed ID: 18821942
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
    Hagihara M, Shimura T, Yamamoto K, Sujirachato K, Tsuji S, Yamamura M, Tsuji K.
    Tokai J Exp Clin Med; 1993 Jun 01; 18(1-2):61-4. PubMed ID: 7940609
    [Abstract] [Full Text] [Related]

  • 20. Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens.
    Ciprandi G, Contini P, Murdaca G, DeAmici M, Gallina AM, Puppo F.
    Int Immunopharmacol; 2009 Aug 01; 9(9):1058-62. PubMed ID: 19410660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.